secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adicet Bio, Inc. (ACET)
CIK:        0001720580
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0000950170-25-053238
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Adicet Bio receives Nasdaq delisting notice for bid price below $1; cure period to Oct 6, 2025
--------------------------------------------------------------------------------

- Received Nasdaq notice on April 7, 2025 for non-compliance with minimum bid price rule (closing bid <$1 for 30 consecutive days).
- Initial compliance period ends October 6, 2025; must close at or above $1 for at least 10 consecutive days to regain compliance.
- If not cured, may seek additional 180-day period by transferring to Nasdaq Capital Market and meeting other listing standards.
- Company considering reverse stock split as a potential cure; no assurance of regaining compliance or maintaining listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720580/000095017025053238/0000950170-25-053238-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720580/000095017025053238/acet-20250407.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-053238

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer